Does Smoking Reduce Infliximab’s Effectiveness against Crohn’s Disease?

Crohn’s disease (CD) is an idiopathic inflammatory bowel disease and has no known cure. CD symptoms are treated using an array of medicines, including biological agents such as infliximab. However, infliximab therapy is expensive; therefore, identifying variables that can help predict response to in...

Full description

Saved in:
Bibliographic Details
Main Authors: Neeraj Narula, Richard N Fedorak
Format: Article
Language:English
Published: Wiley 2009-01-01
Series:Canadian Journal of Gastroenterology
Online Access:http://dx.doi.org/10.1155/2009/431349
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832559137546829824
author Neeraj Narula
Richard N Fedorak
author_facet Neeraj Narula
Richard N Fedorak
author_sort Neeraj Narula
collection DOAJ
description Crohn’s disease (CD) is an idiopathic inflammatory bowel disease and has no known cure. CD symptoms are treated using an array of medicines, including biological agents such as infliximab. However, infliximab therapy is expensive; therefore, identifying variables that can help predict response to infliximab is worthwhile. The present article reviews the impact of tobacco smoking on the efficacy of infliximab in CD. Earlier studies have speculated that smoking has a negative effect on the response to infliximab in CD, but the current literature is largely unable to identify a significant relationship between the two. Although smoking is known to have a negative effect on the course of CD, as well as other organ systems, presently, a CD patient’s smoking status should not influence treatment decisions regarding infliximab therapy.
format Article
id doaj-art-5f1b2be99ded46e786a0394b3b6161ec
institution Kabale University
issn 0835-7900
language English
publishDate 2009-01-01
publisher Wiley
record_format Article
series Canadian Journal of Gastroenterology
spelling doaj-art-5f1b2be99ded46e786a0394b3b6161ec2025-02-03T01:30:47ZengWileyCanadian Journal of Gastroenterology0835-79002009-01-0123212112510.1155/2009/431349Does Smoking Reduce Infliximab’s Effectiveness against Crohn’s Disease?Neeraj Narula0Richard N Fedorak1Division of Gastroenterology, University of Alberta, Edmonton, Alberta, CanadaDivision of Gastroenterology, University of Alberta, Edmonton, Alberta, CanadaCrohn’s disease (CD) is an idiopathic inflammatory bowel disease and has no known cure. CD symptoms are treated using an array of medicines, including biological agents such as infliximab. However, infliximab therapy is expensive; therefore, identifying variables that can help predict response to infliximab is worthwhile. The present article reviews the impact of tobacco smoking on the efficacy of infliximab in CD. Earlier studies have speculated that smoking has a negative effect on the response to infliximab in CD, but the current literature is largely unable to identify a significant relationship between the two. Although smoking is known to have a negative effect on the course of CD, as well as other organ systems, presently, a CD patient’s smoking status should not influence treatment decisions regarding infliximab therapy.http://dx.doi.org/10.1155/2009/431349
spellingShingle Neeraj Narula
Richard N Fedorak
Does Smoking Reduce Infliximab’s Effectiveness against Crohn’s Disease?
Canadian Journal of Gastroenterology
title Does Smoking Reduce Infliximab’s Effectiveness against Crohn’s Disease?
title_full Does Smoking Reduce Infliximab’s Effectiveness against Crohn’s Disease?
title_fullStr Does Smoking Reduce Infliximab’s Effectiveness against Crohn’s Disease?
title_full_unstemmed Does Smoking Reduce Infliximab’s Effectiveness against Crohn’s Disease?
title_short Does Smoking Reduce Infliximab’s Effectiveness against Crohn’s Disease?
title_sort does smoking reduce infliximab s effectiveness against crohn s disease
url http://dx.doi.org/10.1155/2009/431349
work_keys_str_mv AT neerajnarula doessmokingreduceinfliximabseffectivenessagainstcrohnsdisease
AT richardnfedorak doessmokingreduceinfliximabseffectivenessagainstcrohnsdisease